These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 1385143)

  • 1. Prediction of pelvic lymph node metastases by a prostate-specific antigen and prostatic acid phosphatase in clinical T3/T4M0 prostatic cancer.
    Waehre H; Wanderaas EH; Paus E; Fosså SD
    Eur Urol; 1992; 22(1):33-8. PubMed ID: 1385143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate-specific antigen and prostatic acid phosphatase in the detection of early prostate cancer and in the prediction of regional lymph node metastases.
    Wirth MP; Frohmüller HG
    Eur Urol; 1992; 21(4):263-8. PubMed ID: 1281102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate-specific antigen and prostate acid phosphatase in the detection of early prostate cancer and the prediction of regional lymph node metastases.
    Wirth MP; Frohmüller HG
    Eur Urol; 1992; 22(1):27-32. PubMed ID: 1385142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA ploidy, serum prostate specific antigen, histological grade and immunohistochemistry as predictive parameters of lymph node metastases in T1-T3/M0 prostatic adenocarcinoma.
    Berner A; Waere H; Nesland JM; Paus E; Danielsen HE; Fosså SD
    Br J Urol; 1995 Jan; 75(1):26-32. PubMed ID: 7531589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of preoperative serum prostate-specific antigen concentration and biopsy Gleason score in predicting risk of pelvic lymph node metastases in prostate cancer.
    Narayan P; Fournier G; Gajendran V; Leidich R; Lo R; Wolf JS; Jacob G; Nicolaisen G; Palmer K; Freiha F
    Urology; 1994 Oct; 44(4):519-24. PubMed ID: 7524237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results of laparoscopic pelvic lymphadenectomy in patients at high risk for nodal metastases from prostate cancer.
    Kava BR; Dalbagni G; Conlon KC; Russo P
    Ann Surg Oncol; 1998 Mar; 5(2):173-80. PubMed ID: 9527271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reliability of preoperative values to determine the need for lymphadenectomy in patients with prostate cancer and meticulous lymph node dissection.
    Burkhard FC; Bader P; Schneider E; Markwalder R; Studer UE
    Eur Urol; 2002 Aug; 42(2):84-90; discussion 90-2. PubMed ID: 12160577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The incidence of lymph node metastases in prostate carcinoma depends not only on tumor characteristics but also on surgical performance and extent of pelvic lymphadenectomy.
    Klevecka V; Musch M; Roggenbuck U; Stoerkel S; Kroepfl D
    Medicina (Kaunas); 2008; 44(8):601-8. PubMed ID: 18791337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of prostate-specific antigen in untreated prostatic carcinoma.
    Oosterom R; Bogdanowicz J; Schröder FH
    Eur Urol; 1989; 16(4):253-7. PubMed ID: 2475344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laparoscopic pelvic lymph node dissection allows significantly more accurate staging in "high-risk" prostate cancer compared to MRI or CT.
    Borley N; Fabrin K; Sriprasad S; Mondaini N; Thompson P; Muir G; Poulsen J
    Scand J Urol Nephrol; 2003; 37(5):382-6. PubMed ID: 14594685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The staging pelvic lymphadenectomy: implications as an adjunctive procedure for clinically localized prostate cancer.
    Alagiri M; Colton MD; Seidmon EJ; Greenberg RE; Hanno PM
    Br J Urol; 1997 Aug; 80(2):243-6. PubMed ID: 9284196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detecting lymph nodes metastasis in prostate cancer through extended vs. standard laparoscopic pelvic lymphadenectomy.
    Arenas LF; Füllhase C; Boemans P; Fichtner J
    Aktuelle Urol; 2010 Jan; 41 Suppl 1():S10-4. PubMed ID: 20094944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Re-evaluation of the need for pelvic lymphadenectomy in low grade prostate cancer.
    Fournier GR; Narayan P
    Br J Urol; 1993 Oct; 72(4):484-8. PubMed ID: 7505192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of prostate-specific antigen and prostatic acid phosphatase in untreated prostatic carcinoma and benign prostatic hyperplasia.
    Bogdanowicz JF; Bentvelsen FM; Oosterom R; Schroeder FH
    Scand J Urol Nephrol Suppl; 1991; 138():97-103. PubMed ID: 1723815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eliminating the need for bilateral pelvic lymphadenectomy in select patients with prostate cancer.
    Bluestein DL; Bostwick DG; Bergstralh EJ; Oesterling JE
    J Urol; 1994 May; 151(5):1315-20. PubMed ID: 7512662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The value of acid phosphatase measurements in predicting extraprostatic cancer growth before radical prostatectomy.
    Salo JO; Rannikko S
    Br J Urol; 1988 Nov; 62(5):439-42. PubMed ID: 3208023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of preoperative plasma endoglin for prediction of lymph node metastasis in patients with clinically localized prostate cancer.
    Karam JA; Svatek RS; Karakiewicz PI; Gallina A; Roehrborn CG; Slawin KM; Shariat SF
    Clin Cancer Res; 2008 Mar; 14(5):1418-22. PubMed ID: 18316564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of lymphatic spreading in prostatic cancer by prostate-specific antigen and Gleason's score.
    Wu TT; Chen KK; Huang JK; Lee YH; Chen MT; Chang LS
    Eur Urol; 1994; 26(3):202-6. PubMed ID: 7528661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate specific antigen level and Gleason score in predicting the stage of newly diagnosed prostate cancer.
    Spencer JA; Chng WJ; Hudson E; Boon AP; Whelan P
    Br J Radiol; 1998 Nov; 71(851):1130-5. PubMed ID: 10434906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Value of PSA and (pre- postoperative) Gleason in predicting the potential lymphatic involvement in patients with prostatic cancer].
    Gómez Veiga F; Díaz Bermúdez J; Alvarez Castelo L; Lorenzo Patiño MJ; Rodríguez Rivera J; Chantada Abal V; Vázquez Martul E; González Martín M
    Arch Esp Urol; 1997; 50(1):33-9. PubMed ID: 9182486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.